Exact Mass: 445.1995
Exact Mass Matches: 445.1995
Found 500 metabolites which its exact mass value is equals to given mass value 445.1995
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
tridihexethyl iodide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
cerdulatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Tak-593
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
N-Oxide abiraterone sulfate
N-Oxide abiraterone sulfate is a metabolite of abiraterone. Abiraterone is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) (prostate cancer not responding to androgen deprivation or treatment with antiandrogens). It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. (Wikipedia)
P-Hydroxyhippuryl-his-leu-OH
Ala Ile Asn Glu
Ile Ala Gln Asp
Ala Val Gln Glu
Asn Ile Ala Glu
Ala Cys Pro Arg
Ala Cys Arg Pro
Ala Asp Ile Gln
Ala Asp Leu Gln
Ala Asp Gln Ile
Ala Asp Gln Leu
Ala Glu Ile Asn
Ala Glu Leu Asn
Ala Glu Asn Ile
Ala Glu Asn Leu
Ala Glu Gln Val
Ala Glu Val Gln
Ala Ile Asp Gln
Ala Ile Glu Asn
Ala Ile Gln Asp
Ala Leu Asp Gln
Ala Leu Glu Asn
Ala Leu Asn Glu
Ala Leu Gln Asp
Ala Met Pro Gln
Ala Met Gln Pro
Ala Asn Glu Ile
Ala Asn Glu Leu
Ala Asn Ile Glu
Ala Asn Leu Glu
Ala Asn Asn Gln
Ala Asn Gln Asn
Ala Pro Cys Arg
Ala Pro Met Gln
Ala Pro Gln Met
Ala Pro Arg Cys
Ala Gln Asp Ile
Ala Gln Asp Leu
Ala Gln Glu Val
Ala Gln Ile Asp
Ala Gln Leu Asp
Ala Gln Met Pro
Ala Gln Asn Asn
Ala Gln Pro Met
Ala Gln Val Glu
Ala Arg Cys Pro
Ala Arg Pro Cys
Ala Val Glu Gln
Cys Ala Pro Arg
Cys Ala Arg Pro
Cys Ile Asn Pro
Cys Ile Pro Asn
Cys Leu Asn Pro
Cys Leu Pro Asn
Cys Asn Ile Pro
Cys Asn Leu Pro
Cys Asn Pro Ile
Cys Asn Pro Leu
Cys Pro Ala Arg
Cys Pro Ile Asn
Cys Pro Leu Asn
Cys Pro Asn Ile
Cys Pro Asn Leu
Cys Pro Gln Val
Cys Pro Arg Ala
Cys Pro Val Gln
Cys Gln Pro Val
Cys Gln Val Pro
Cys Arg Ala Pro
Cys Arg Pro Ala
Cys Val Pro Gln
Cys Val Gln Pro
Asp Ala Ile Gln
Asp Ala Leu Gln
Asp Ala Gln Ile
Asp Ala Gln Leu
Asp Ile Ala Gln
Asp Ile Gln Ala
Asp Lys Pro Ser
Asp Lys Ser Pro
Asp Leu Ala Gln
Asp Leu Gln Ala
Asp Asn Pro Thr
Asp Asn Thr Pro
Asp Asn Val Val
Asp Pro Lys Ser
Asp Pro Asn Thr
Asp Pro Gln Ser
Asp Pro Ser Lys
Asp Pro Ser Gln
Asp Pro Thr Asn
Asp Gln Ala Ile
Asp Gln Ala Leu
Asp Gln Ile Ala
Asp Gln Leu Ala
Asp Gln Pro Ser
Asp Gln Ser Pro
Asp Ser Lys Pro
Asp Ser Pro Lys
Asp Ser Pro Gln
Asp Ser Gln Pro
Asp Thr Asn Pro
Asp Thr Pro Asn
Asp Val Asn Val
Asp Val Val Asn
Glu Ala Ile Asn
Glu Ala Leu Asn
Glu Ala Asn Ile
Glu Ala Asn Leu
Glu Ala Gln Val
Glu Ala Val Gln
Glu Gly Ile Gln
Glu Gly Leu Gln
Glu Gly Gln Ile
Glu Gly Gln Leu
Glu Ile Ala Asn
Glu Ile Gly Gln
Glu Ile Asn Ala
Glu Ile Gln Gly
Glu Leu Ala Asn
Glu Leu Gly Gln
Glu Leu Asn Ala
Glu Leu Gln Gly
Glu Asn Ala Ile
Glu Asn Ala Leu
Glu Asn Ile Ala
Glu Asn Leu Ala
Glu Asn Pro Ser
Glu Asn Ser Pro
Glu Pro Asn Ser
Glu Pro Ser Asn
Glu Gln Ala Val
Glu Gln Gly Ile
Glu Gln Gly Leu
Glu Gln Ile Gly
Glu Gln Leu Gly
Glu Gln Val Ala
Glu Ser Asn Pro
Glu Ser Pro Asn
Glu Val Ala Gln
Glu Val Gln Ala
Gly Glu Ile Gln
Gly Glu Leu Gln
Gly Glu Gln Ile
Gly Glu Gln Leu
Gly Ile Glu Gln
Gly Ile Gln Glu
Gly Leu Glu Gln
Gly Leu Gln Glu
Gly Asn Gln Gln
Gly Pro Ser Trp
Gly Pro Trp Ser
Gly Gln Glu Ile
Gly Gln Glu Leu
Gly Gln Ile Glu
Gly Gln Leu Glu
Gly Gln Asn Gln
Gly Gln Gln Asn
Gly Ser Pro Trp
Gly Ser Trp Pro
Gly Trp Pro Ser
Gly Trp Ser Pro
Ile Ala Asp Gln
Ile Ala Glu Asn
Ile Ala Asn Glu
Ile Cys Asn Pro
Ile Cys Pro Asn
Ile Asp Ala Gln
Ile Asp Gln Ala
Ile Glu Ala Asn
Ile Glu Gly Gln
Ile Glu Asn Ala
Ile Glu Gln Gly
Ile Gly Glu Gln
Ile Gly Gln Glu
Ile Asn Ala Glu
Ile Asn Cys Pro
Ile Asn Glu Ala
Ile Asn Pro Cys
Ile Pro Cys Asn
Ile Pro Asn Cys
Ile Gln Ala Asp
Ile Gln Asp Ala
Ile Gln Glu Gly
Ile Gln Gly Glu
Lys Asp Pro Ser
Lys Asp Ser Pro
Lys Pro Asp Ser
Lys Pro Ser Asp
Lys Ser Asp Pro
Lys Ser Pro Asp
Leu Ala Asp Gln
Leu Ala Glu Asn
Leu Ala Asn Glu
Leu Ala Gln Asp
Leu Cys Asn Pro
Leu Cys Pro Asn
Leu Asp Ala Gln
Leu Asp Gln Ala
Leu Glu Ala Asn
Leu Glu Gly Gln
Leu Glu Asn Ala
Leu Glu Gln Gly
Leu Gly Glu Gln
Leu Gly Gln Glu
Leu Asn Ala Glu
Leu Asn Cys Pro
Leu Asn Glu Ala
Leu Asn Pro Cys
Leu Pro Cys Asn
Leu Pro Asn Cys
Leu Gln Ala Asp
Leu Gln Asp Ala
Leu Gln Glu Gly
Leu Gln Gly Glu
Met Ala Pro Gln
Met Ala Gln Pro
Met Pro Ala Gln
Met Pro Gln Ala
Met Gln Ala Pro
Met Gln Pro Ala
Asn Ala Glu Ile
Asn Ala Glu Leu
Asn Ala Ile Glu
Asn Ala Leu Glu
Asn Ala Asn Gln
Asn Ala Gln Asn
Asn Cys Ile Pro
Asn Cys Leu Pro
Asn Cys Pro Ile
Asn Cys Pro Leu
Asn Asp Pro Thr
Asn Asp Thr Pro
Asn Asp Val Val
Asn Glu Ala Ile
Asn Glu Ala Leu
Asn Glu Ile Ala
Asn Glu Leu Ala
Asn Glu Pro Ser
Asn Glu Ser Pro
Asn Gly Gln Gln
Asn Ile Cys Pro
Asn Ile Glu Ala
Asn Ile Pro Cys
Asn Leu Ala Glu
Asn Leu Cys Pro
Asn Leu Glu Ala
Asn Leu Pro Cys
Asn Asn Ala Gln
Asn Asn Gln Ala
Asn Pro Cys Ile
Asn Pro Cys Leu
Asn Pro Ile Cys
Asn Pro Leu Cys
Asn Gln Ala Asn
Asn Gln Gly Gln
Asn Gln Asn Ala
Asn Gln Gln Gly
Asn Val Asp Val
Asn Val Val Asp
Pro Ala Cys Arg
Pro Ala Met Gln
Pro Ala Gln Met
Pro Ala Arg Cys
Pro Cys Ala Arg
Pro Cys Ile Asn
Pro Cys Leu Asn
Pro Cys Asn Ile
Pro Cys Asn Leu
Pro Cys Gln Val
Pro Cys Arg Ala
Pro Cys Val Gln
Pro Asp Lys Ser
Pro Asp Ser Lys
Pro Gly Ser Trp
Pro Gly Trp Ser
Pro Ile Cys Asn
Pro Ile Asn Cys
Pro Lys Asp Ser
Pro Lys Ser Asp
Pro Leu Cys Asn
Pro Leu Asn Cys
Pro Met Ala Gln
Pro Met Gln Ala
Pro Asn Cys Ile
Pro Asn Cys Leu
Pro Asn Ile Cys
Pro Asn Leu Cys
Pro Gln Ala Met
Pro Gln Cys Val
Pro Gln Met Ala
Pro Gln Thr Thr
Pro Gln Val Cys
Pro Arg Ala Cys
Pro Arg Cys Ala
Pro Ser Asp Lys
Pro Ser Gly Trp
Pro Ser Lys Asp
Pro Ser Trp Gly
Pro Thr Gln Thr
Pro Thr Thr Gln
Pro Val Cys Gln
Pro Val Gln Cys
Pro Trp Gly Ser
Pro Trp Ser Gly
Gln Ala Asp Ile
Gln Ala Asp Leu
Gln Ala Glu Val
Gln Ala Ile Asp
Gln Ala Leu Asp
Gln Ala Met Pro
Gln Ala Asn Asn
Gln Ala Pro Met
Gln Ala Val Glu
Gln Cys Pro Val
Gln Cys Val Pro
Gln Asp Ala Ile
Gln Asp Ala Leu
Gln Asp Ile Ala
Gln Asp Leu Ala
Gln Glu Ala Val
Gln Glu Gly Ile
Gln Glu Gly Leu
Gln Glu Ile Gly
Gln Glu Leu Gly
Gln Glu Val Ala
Gln Gly Glu Ile
Gln Gly Glu Leu
Gln Gly Ile Glu
Gln Gly Leu Glu
Gln Gly Asn Gln
Gln Gly Gln Asn
Gln Ile Ala Asp
Gln Ile Asp Ala
Gln Ile Glu Gly
Gln Ile Gly Glu
Gln Leu Ala Asp
Gln Leu Asp Ala
Gln Leu Glu Gly
Gln Leu Gly Glu
Gln Met Ala Pro
Gln Met Pro Ala
Gln Asn Ala Asn
Gln Asn Gly Gln
Gln Asn Asn Ala
Gln Asn Gln Gly
Gln Pro Ala Met
Gln Pro Cys Val
Gln Pro Met Ala
Gln Pro Thr Thr
Gln Pro Val Cys
Gln Gln Gly Asn
Gln Gln Asn Gly
Gln Thr Pro Thr
Gln Thr Thr Pro
Gln Val Ala Glu
Gln Val Cys Pro
Gln Val Glu Ala
Gln Val Pro Cys
Arg Ala Cys Pro
Arg Ala Pro Cys
Arg Cys Ala Pro
Arg Cys Pro Ala
Arg Pro Ala Cys
Arg Pro Cys Ala
Ser Asp Lys Pro
Ser Asp Pro Lys
Ser Gly Pro Trp
Ser Gly Trp Pro
Ser Lys Asp Pro
Ser Lys Pro Asp
Ser Pro Asp Lys
Ser Pro Gly Trp
Ser Pro Lys Asp
Ser Pro Trp Gly
Ser Trp Gly Pro
Ser Trp Pro Gly
Thr Pro Gln Thr
Thr Pro Thr Gln
Thr Gln Pro Thr
Thr Gln Thr Pro
Thr Thr Pro Gln
Thr Thr Gln Pro
Val Ala Glu Gln
Val Ala Gln Glu
Val Cys Pro Gln
Val Cys Gln Pro
Val Asp Asn Val
Val Asp Val Asn
Val Glu Ala Gln
Val Glu Gln Ala
Val Asn Asp Val
Val Asn Val Asp
Val Pro Cys Gln
Val Pro Gln Cys
Val Gln Ala Glu
Val Gln Cys Pro
Val Gln Glu Ala
Val Gln Pro Cys
Val Val Asp Asn
Val Val Asn Asp
Trp Gly Pro Ser
Trp Gly Ser Pro
Trp Pro Gly Ser
Trp Pro Ser Gly
Trp Ser Gly Pro
Trp Ser Pro Gly
PC(6:2/6:2)
3,4-Dimethoxy-N-[3-(1,2,3,4-tetrahydro-7-isoquinolinylcarbamoyl)b enzyl]benzamide
magnesium 1,4-bis(2-ethylhexyl) 2-sulphonatosuccinate
N4-BENZOYL-5-O-TERT-BUTYLDIMETHYLSILYL-2-DEOXYCYTIDINE
5-O-TBDMS-N4-Benzoyl-2-deoxycytidine is a modified nucleoside. 5-O-TBDMS-N4-Benzoyl-2-deoxycytidine can be used in the synthesis of deoxyribonucleic acid or nucleic acid.
3-(5-[(FLUOREN-9-YLMETHOXY)CARBONYLAMINO]PENTYLOXY)BENZOIC ACID
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(4-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(2-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)
Selonsertib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
(2S,5S)-1-(4-(tert-butyl)phenyl)-2,5-bis(4-nitrophenyl)pyrrolidine
(2E)-9-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}non-2-enoic acid
(2E,8R)-8-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}non-2-enoic acid
4-(2-Aminoethoxy)-N-(3-Chloro-2-Ethoxy-5-Piperidin-1-Ylphenyl)-3,5-Dimethylbenzamide
1-((1R)-1-(Hydroxymethyl)-3-{6-[(3-phenylpropanoyl)amino]-1H-indol-1-YL}propyl)-1H-imidazole-4-carboxamide
[10,13-dimethyl-17-(1-oxidopyridin-1-ium-3-yl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
2-Cyano-2-[3-[4-(phenylmethyl)-1-piperazinyl]-2-quinoxalinyl]acetic acid 2-methoxyethyl ester
2-(2,4-Dimethoxyphenyl)-5-methyl-4-[[4-(4-quinazolinyl)-1-piperazinyl]methyl]oxazole
6-N-(furan-2-ylmethyl)-4-N-(4-methoxyphenyl)-2-N-[(E)-(4-methoxyphenyl)methylideneamino]-1,3,5-triazine-2,4,6-triamine
1-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-3-(2-methoxyphenyl)-1-(3-pyridinylmethyl)thiourea
N-[(E)-(4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ylidene)amino]benzamide
8-methoxy-3-[(E)-[4-methoxy-3-(1-pyrrolidinylmethyl)phenyl]methylideneamino]-2-methyl-5H-pyrimido[5,4-b]indol-4-one
(2R,3R,3aS,9bS)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-2-(morpholine-4-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(1R,9S,10S,11S)-10-(hydroxymethyl)-5-(4-methoxyphenyl)-12-methyl-6-oxo-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2S,3S,3aR,9bR)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-2-[4-morpholinyl(oxo)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(3R)-3-(2-hydroxyethyl)-N,N-dimethyl-2-(1-oxopropyl)-4-[3-(5-pyrimidinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(1S,9R,10R,11R)-10-(hydroxymethyl)-5-(4-methoxyphenyl)-12-methyl-6-oxo-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(2S,3S)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone
[(2R,3R)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone
(1S,19S)-9,9,16,16-tetramethyl-14-oxido-8-oxa-23,25-diaza-14-azoniaheptacyclo[17.5.2.01,17.03,15.04,13.07,12.019,23]hexacosa-2,4(13),5,7(12),10,14-hexaene-24,26-dione
(1S,3S,12Z)-1-hydroxy-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.018,23]hexacosa-8,12,15,17(26),18(23),19,24-heptaene-4,10-dione
estrone 3-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of estrone 3-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
PQR620
PQR620 is an orally bioavailable and selective brain penetrant inhibitor of mTORC1/2[1]. PQR620 is an orally bioavailable and selective brain penetrant inhibitor of mTORC1/2[1].
Samelisant
Samelisant (SUVN-G3031) is a potent and selective histamine H3 receptor (H3R) inverse agonist with good brain penetration and oral bioavailability. Samelisant has a similar binding affinity towards human (hH3R; Ki=8.7 nM) and rat (rH3R;Ki=9.8 nM) H3R indicating no inter-species differences. Samelisant can be used for the research of sleep-related disorders[1].